Prostate cancer risk calculatorProstate Health IndexValidationBackground Risk prediction models for prostate cancer (PCa) have become important tools in reducing unnecessary prostate biopsies. The Prostate Health Index (PHI) may increase the predictive accuracy of such models. Objectives To compare two ...
Serum-based biomarkers Prostate health index (PHI) The PHI test is a serum-based analysis, developed by Beckman Coulter Inc. and the National Cancer Institute-Early Detection Research Network. The biomarkers included in the PHI are [-2] proPSA, free PSA (fPSA), and total PSA (tPSA). Thes...
Serum-based biomarkers Prostate health index (PHI) The PHI test is a serum-based analysis, developed by Beckman Coulter Inc. and the National Cancer Institute-Early Detection Research Network. The biomarkers included in the PHI are [-2] proPSA, free PSA (fPSA), and total PSA (tPSA). Thes...
Performance Measure Calculations for High-Grade Cancer using PSA Alone, Prostate Cancer Prevention Trial Risk Calculator, Prostate Health Index (PHI), Derived Multiplex 2-Gene and 3-Gene Models, MyProstateScore (MPS), MPS2, and MPS2 Plus Prostate Volume (MPS2+) in the EDRN Validation Cohort ...
Abrate A, Lazzeri M, Lughezzani G, et al. Clinical performance of Prostate Health Index (PHI) for prediction of prostate cancer in obese men: data from a multicenter European prospective study, PROMEtheuS project. BJU Int. 2015;115:537–45. ...
3.4.1. Prostate health index (Phi) A novel approach to improve the clinical performance of PSA is to combine the results of three automated blood tests (tPSA, fPSA, and [-2] proPSA) using a mathematical formula termed the Phi. The Phi test specifically uses the formula ([-2] proPSA/...
This study evaluates the potential of urinary testing for TMPRSS2:ERG and PCA3 RNA to improve detection of aggressive prostate cancer and reduce health
1.Preoperativeprostatehealthindexpredictspoorpatho- logicoutcomesofradicalprostatectomyinpatientswith biopsy-detectedlow-riskpatientsprostatecancer:results fromaChineseprospectivecohort[1].Thisarticle summarizedthevalueofpreoperativeprostatehealth index(PHI)inpredictingpoorpathologicfeaturesin biopsy-detectedlow-riskChinese...
New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index 2022, Prostate The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer 2022, World Jour...
Comparison between the four-kallikrein panel and prostate health index for predicting prostate cancer. Eur Urol. 2015;68(1):139-146.PubMedGoogle ScholarCrossref 14. Chevli KK, Duff M, Walter P, et al. Urinary PCA3 as a predictor of prostate cancer in a cohort of 3,073 men undergoing ...